Noriko Motoi

28PUBLICATIONS
119CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Nov 24, 2025
Impacts of Mitochondrial Status After Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma Patients.

Kotaro Sugawara, Shingo Sakashita, Takashi Fukuda

|Sep 13, 2025
Tumor Cell Proportion Assessment in Advanced Non-Squamous Non-Small Cell Lung Cancer Tissue Samples in Real-World Settings in Japan: The ASTRAL Study.

Kanako C Hatanaka, Kazumi Nishino, Tomoyuki Yokose

|Jul 08, 2025
EML4-ALK Rearrangement Creates a Distinctive Myeloid Cell-Dominant Immunosuppressive Microenvironment in Lung Cancer.

Kosuke Arai, Yukari Nishito, Hideaki Mizuno

|Jan 14, 2025
Schlafen 11 Expression in Patients With Small Cell Lung Cancer and Its Association With Clinical Outcomes.

Ken Masuda, Tatsuya Yoshida, Noriko Motoi

|Dec 07, 2024
Survival Impacts of Mitochondrial Status in Esophageal Squamous Cell Carcinoma Patients.

Kotaro Sugawara, Shingo Sakashita, Takashi Fukuda

|Jun 19, 2024
Evaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists' Visual Estimates.

Tomoharu Kiyuna, Eric Cosatto, Kanako C Hatanaka

Pageof 5

Frequent Collaborators

4 joint publications

Yusuke Okuma

4 joint publications

Hidehito Horinouchi

4 joint publications

Nobuyoshi Hiraoka

4 joint publications

Kouya Shiraishi